pLv-CMV-MyoD-ER(T) Citations (3)

Originally described in: Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
Kimura E, Han JJ, Li S, Fall B, Ra J, Haraguchi M, Tapscott SJ, Chamberlain JS Hum Mol Genet. 2008 Aug 15. 17(16):2507-17. PubMed Journal

---

Articles Citing pLv-CMV-MyoD-ER(T)

Articles
Transplantation of induced pluripotent stem cell-derived mesoangioblast-like myogenic progenitors in mouse models of muscle regeneration. Gerli MF, Maffioletti SM, Millet Q, Tedesco FS. J Vis Exp. 2014 Jan 20;(83):e50532. doi: 10.3791/50532. PubMed
Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease. Kim EY, Page P, Dellefave-Castillo LM, McNally EM, Wyatt EJ. Skelet Muscle. 2016 Sep 15;6:32. doi: 10.1186/s13395-016-0103-9. eCollection 2016. PubMed
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. Kim EY, Barefield DY, Vo AH, Gacita AM, Schuster EJ, Wyatt EJ, Davis JL, Dong B, Sun C, Page P, Dellefave-Castillo L, Demonbreun A, Zhang HF, McNally EM. JCI Insight. 2019 Mar 21;4(6). pii: 122686. doi: 10.1172/jci.insight.122686. eCollection 2019 Mar 21. PubMed

If you have published an article using this material, please email us at to have your article added to this page.